(MedPage Today) — People with obesity and alcohol use disorder had fewer heavy drinking days while on semaglutide (Wegovy), a Danish randomized trial showed.
Alongside cognitive behavioral therapy, adults receiving a 2.4-mg weekly dose of the…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
